3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
16
Carcinoma, Non-Small-Cell Lung
8
Small Cell Lung Carcinoma
4
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Breast Neoplasms
4
Sarcoma
3
Rectal Neoplasms
3
Oropharyngeal Neoplasms
3
Carcinoma, Hepatocellular
3
Melanoma
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Thrombosis
1
Stroke
1
Solid Tumor, Adult
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Pulmonary Disease, Chronic Obstructive
1
Precancerous Conditions
1
Pathologic Complete Response
1
Osteoporosis
1
Nevus, Pigmented
1
Neurofibrosarcoma
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
regorafenib
1
X-Rays
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiotherapy
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Exercise
1
Endoscopy
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pathologic Complete Response
×
X-Rays
×
Clear all
NCT02233374
2022-10-28
PRISM
Royal North Shore Hospital
Phase NA
Completed
27 enrolled